X
Inozyme plans $75m IPO as it heads for clinic with rare bone diseases drug
https://pharmaphorum.com/news/inozyme-plans-75-ipo-as-it-heads-for-clinic-with-rare-bone-diseases-drug/
bone
US regulator approves new use for Amgen bone drug
New use in multiple myeloma for Xgeva
Amgen’s Prolia succeeds in glucocorticoid-induced osteoporosis
Possible new use for well-established drug.